Show simple item record

dc.contributor.authorHaberer, Jessica E.
dc.contributor.authorMusiimenta, Angella
dc.contributor.authorAtukunda, Esther Cathyln
dc.contributor.authorMusinguzi, Nicholas
dc.contributor.authorWyatt, Monique A
dc.contributor.authorWare, Norma C
dc.contributor.authorBangsberg, David R
dc.date.accessioned2022-04-21T14:28:28Z
dc.date.available2022-04-21T14:28:28Z
dc.date.issued2016
dc.identifier.citationHaberer, J. E., Musiimenta, A., Atukunda, E. C., Musinguzi, N., Wyatt, M. A., Ware, N. C., & Bangsberg, D. R. (2016). Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS (London, England), 30(8), 1295.en_US
dc.identifier.isbn0269-9370
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/1791
dc.descriptionAdherence monitoring improve antiretroviral therapy adherence in rural Uganda.en_US
dc.description.abstractObjective: To explore the effects of four types of short message service (SMS) plus real time adherence monitoring on antiretroviral therapy (ART) adherence: daily reminders, weekly reminders, reminders triggered after a late or missed dose (delivered to patients), and notifications triggered by sustained adherence lapses (delivered to patient-nominated social supporters). Design: Pilot randomized controlled trial. Methods: Sixty-three individuals initiating ART received a real-time adherence monitor and were randomized (1 : 1 : 1): (1) Scheduled SMS reminders (daily for 1 month, weekly for 2 months), then SMS reminders triggered by a late or missed dose (no monitoring signal within 2 h of expected dosing); SMS notifications to social supporters for sustained adherence lapses (no monitoring signal for >48 h) added after 3 months. (2) Triggered SMS reminders starting at enrolment; SMS notifications to social supporters added after 3 months. (3) Control: No SMS. HIV RNA was determined at 9 months. Percentage adherence and adherence lapses were compared by linear generalized estimating equations and Poisson regression, respectively. Results: Median age was 31 years, 65% were women, and median enrollment CD4þ cell count was 322 cells/ml 97% took once daily tenofovir/emtricitabine/efavirenz. Compared to control, adherence was 11.1% higher (P¼0.04) and more than 48-h lapses were less frequent (IRR 0.6, P¼0.02) in the scheduled SMS arm. Adherence and more than 48-h lapses were similar in the triggered SMS arm and control. No differences in HIV RNA were seen. Conclusion: Scheduled SMS reminders improved ART in the context of real-time monitoring. Larger studies are needed to determine the impact of triggered reminders and role of social supporters in improving adherence.en_US
dc.language.isoenen_US
dc.publisherWolters Kluwer Health, Inc.en_US
dc.subjectAntiretroviral therapy, real-time adherence monitoring, short message service (SMS)en_US
dc.titleShort message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Ugandaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record